Dr. Paul L. Katzenstein, MD

Dr. Katzenstein practices at Uva Rheumatology Pantops - 2536 - HOPD in Charlottesville, Virginia.

Dr. Katzenstein's NPI, 1982692588, was assigned on October 10, 2005. Dr. Katzenstein graduated from University of Maryland School of Medicine - Baltimore in 1983. Dr. Katzenstein holds Virginia license 0101262174.

Dr. Katzenstein's primary practice is Uva Rheumatology Pantops - 2536 - HOPD, at 650 Peter Jefferson Pkwy, Charlottesville, VA 22911.

Dr. Katzenstein's primary practice is Uva Rheumatology Pantops - 2536 - HOPD in Charlottesville, Virginia. Dr. Katzenstein is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Katzenstein to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Katzenstein's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katzenstein practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Katzenstein's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Katzenstein is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Katzenstein's licenses on file in 6 states: Virginia, Kansas, Missouri, Texas, Maryland and Ohio.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Katzenstein treats.

CMS data shows 551 Medicare services from Dr. Katzenstein across 5 procedure codes in 2024, for 265 Medicare patients. Medicare paid $29,028 for them. Every service was in an office.

CMS counts 265 Medicare patients who saw Dr. Katzenstein in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have arthritis, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katzenstein's median patient age at 62, with 69% women.

In 2024, Dr. Katzenstein wrote 1,173 Medicare Part D claims for 196 patients. 83% of them were for generic drugs. CMS names the drug for 1,017 of them, across 22 drugs with 11 or more claims each, at $806,275 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Katzenstein for performance year 2024, reported as part of a group. Dr. Katzenstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katzenstein as offering telehealth.

Dmand AI links 4 papers to Dr. Katzenstein. The most frequent topics are Osteoarthritis, Osteochondrodysplasias and Pedigree. Dr. Katzenstein's most frequent co-authors are Mini N. Pathria, MD and Alan N. Baer, MD.

Dmand AI links Dr. Katzenstein to 5 clinical trials. Conditions studied include Axial Spondyloarthritis, Spondylitis, Ankylosing and Arthritis, Rheumatoid. Eli Lilly and Company sponsors the most, 5.

Dmand AI lists 3 awards for Dr. Katzenstein, most recently CMS Stage 1 EHR in 2013.

Dr. Katzenstein graduated from University of Maryland School of Medicine - Baltimore in 1983. Dr. Katzenstein is a member of ACR.

Dr. Katzenstein is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.